Fundraising FoxPathovax
Baltimore, US · Founded 2014 · Maryland LLC
Find your way into Pathovax
Sign up to see every warm intro you have to Pathovax
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pathovax team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Pathovax was founded in 2014 by Weijie Poh and Joshua Weiyuan Wang.
WP
Weijie PohManager
JW
Joshua Weiyuan WangManager
Reported raises · per SEC filings
Form D private placements$2.8M disclosed across 1 round · 2018
▶$2.8MraisedAug 2018 · 2 investors · BiotechnologyRule 506(b)
▶$2.8MraisedAug 2018 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Weijie PohDirector, Promoter
- Joshua Weiyuan WangDirector, Promoter
- Offering amount
- $2.8M
- Amount sold
- $2.8M
- Minimum investment
- $250K
- First sale
- May 2018
- Incorporated
- Limited Liability Company, Maryland, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 6 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase II | 2020 | $671.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.7M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $299.1K |
| National Science Foundation | Phase I | 2018 | $225K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2017 | $300K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- Who founded Pathovax?
- Pathovax was founded by Weijie Poh, Joshua Weiyuan Wang in 2014.
- How much funding has Pathovax raised?
- Pathovax has disclosed $2.8M raised across 1 round.
- Where is Pathovax headquartered?
- Pathovax is headquartered in Baltimore, US.